Intellipharmaceutics International Email Format
Pharmaceutical ManufacturingOntario, Canada11-50 Employees
Intellipharmaceutics International develops and commercializes pharmaceutical products, including both novel and generic oral solid dosage drugs. Its focus lies in controlled-release formulations and strategies to deter opioid abuse. The company is based in Etobicoke, Ontario, Canada, and operates a contract analytical services laboratory in Toronto that offers methods development, validation and transfer, quality control testing, stability testing, and Category 1 abuse-deterrence studies. In 2016, Intellipharmaceutics entered into a license and commercial supply agreement with Mallinckrodt. It trades on OTCQB and the TSX under IPCIF and IPCI.